|
MRPL18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.325660E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.98992000000064E-05 |
| Normal-vs-Stage2 |
3.533800E-02 |
| Normal-vs-Stage3 |
4.318600E-01 |
| Normal-vs-Stage4 |
2.961500E-02 |
| Stage1-vs-Stage2 |
9.821400E-01 |
| Stage1-vs-Stage3 |
2.241400E-03 |
| Stage1-vs-Stage4 |
9.46090000009114E-07 |
| Stage2-vs-Stage3 |
1.098400E-01 |
| Stage2-vs-Stage4 |
9.022100E-04 |
| Stage3-vs-Stage4 |
8.898500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.881200E-03 |
| Normal-vs-AfricanAmerican |
8.142800E-01 |
| Normal-vs-Asian |
4.152800E-01 |
| Caucasian-vs-AfricanAmerican |
2.582000E-01 |
| Caucasian-vs-Asian |
6.829400E-01 |
| AfricanAmerican-vs-Asian |
4.666400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.302100E-03 |
| Normal-vs-Female |
3.978200E-01 |
| Male-vs-Female |
5.069900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.638400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.653600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.634300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.152970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.042000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.989600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.594200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.805200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.762600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.975400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.848100E-02 |
| Normal-vs-Grade 2 |
3.559500E-04 |
| Normal-vs-Grade 3 |
7.048000E-02 |
| Normal-vs-Grade 4 |
2.410400E-01 |
| Grade 1-vs-Grade 2 |
9.163200E-01 |
| Grade 1-vs-Grade 3 |
6.806200E-01 |
| Grade 1-vs-Grade 4 |
1.588820E-01 |
| Grade 2-vs-Grade 3 |
1.247230E-01 |
| Grade 2-vs-Grade 4 |
1.122660E-03 |
| Grade 3-vs-Grade 4 |
1.372090E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.297700E-03 |
| Normal-vs-ccB subtype |
3.936600E-03 |
| ccA subtype-vs-ccB subtype |
8.259000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.018300E-02 |
| Normal-vs-N1 |
8.803800E-01 |
| N0-vs-N1 |
6.460000E-01 |
|
|
